SANUWAVE Health, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
SANUWAVE Health, Inc. (SNWV) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-08-06
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-09-30 was 158.00K shares.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-06-30 was 363.00K shares.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 221.00K shares.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- SANUWAVE Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 58.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |||||
| 2025-12-31 | 221.00K shares 10-K · filed 2026-03-26 | ||||||
| 2025-09-30 | 158.00K shares 10-Q · filed 2025-11-06 | 295.00K shares 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | 363.00K shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-26 | ||||||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-06 | 35.00K shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2025-11-06 | 43.00K shares 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | 13.09M shares 10-Q · filed 2024-08-12 | 0.00 shares 10-Q · filed 2025-08-07 | 17.39M shares 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | 58.00K shares 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | 58.00K shares 10-K · filed 2025-03-20 | ||||||
| 2023-09-30 | 58.00K shares 10-Q · filed 2024-11-07 | 58.00K shares 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | 21.69M shares 10-Q · filed 2024-08-12 | 21.69M shares 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |